Hidradenitis Suppurativa


Bermekimab Goes to Janssen for up to $1.35b in Deal that Could Shake up Future Hidradenitis Suppurativa & Atopic Dermatitis Market

XBiotech’s Bermekimab, a promising experimental drug generating significant interest with Hidradenitis Suppurativa patients in the TrialSite News network, has been sold to Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. Bermekimab is...

Join us as we Talk to Dr. Ashley Biscoe and Dr. Alison Egeland About Hidradenitis Suppurativa and Some Ways to Start Healing

In this podcast, we discuss Hidradenitis Suppurativa and some natural approaches to healing. The Doctors from Attune Functional Medicine go over how the gut and autoimmune/auto-inflammatory disorders like HS can be linked, as well as several other triggers and ways to...

Pin It on Pinterest